Gene Therapy of Pancreatic Ductal Adenocarcinoma

NCT01274455 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Adenocarcinoma

Interventions

GENETIC: Gene Therapy product CYL-02 = plasmid DNA pre-complexed to linear polyethylenimine encoding sst2 + dck::umk genes

Sponsor

University Hospital, Toulouse

Collaborators

[object Object]
[object Object]
[object Object]